$PTGX
看空2022-04-13各周期结果✓ 命中-2.9%
1d
✗ +2.4%
5d
…
21d
✓ -2.9%
原帖
DRUGS · 2022-04-13
Wow weird. $PTGX gets breakthrough therapy designation rescinded for rusfertide. Looks to be due to finding 3 skin cancers after re-enrollment after clinical hold lifted... Oh and PN-943 in 'first half' of 2Q22. https://t.co/iekLPyeXMn
在 X 查看 ↗